Endothelial function in well-developed canine coronary collateral vessels

Am J Physiol. 1993 Feb;264(2 Pt 2):H567-72. doi: 10.1152/ajpheart.1993.264.2.H567.

Abstract

This study examined responses of coronary collateral blood flow to endothelial-dependent vasodilators. Studies were performed in 13 dogs 4-6 mo after embolic occlusion of the left anterior descending coronary artery (LAD). Collateral flow was determined as the sum of retrograde flow from the cannulated LAD, and continuing tissue flow was measured with microspheres administered during the retrograde flow collection. Agonists were introduced into the left main coronary artery to reach collaterals arising from the left coronary arterial system. The endothelial-dependent vasodilators acetylcholine and bradykinin caused 21 +/- 7 and 25 +/- 8% increases of collateral flow, respectively (each P < 0.05). This was not different from the 28 +/- 8% increase in collateral flow produced by nitroglycerin. To determine whether vasodilator prostaglandins contributed to the increased collateral flow, studies were performed after cyclooxygenase blockade with indomethacin (5 mg/kg iv). Indomethacin caused a 30 +/- 9% decrease of retrograde flow during basal conditions but did not blunt the maximum collateral flow rates produced by acetylcholine, bradykinin, or nitroglycerin. These data demonstrate intact endothelial-dependent vasodilator mechanisms in the well-developed coronary collateral circulation.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Acetylcholine / pharmacology
  • Animals
  • Bradykinin / pharmacology
  • Collateral Circulation / drug effects
  • Collateral Circulation / physiology*
  • Coronary Vessels / physiology*
  • Dogs
  • Endothelium, Vascular / physiology*
  • Hemodynamics / drug effects
  • Indomethacin / pharmacology
  • Microspheres
  • Nitroglycerin / pharmacology

Substances

  • Nitroglycerin
  • Acetylcholine
  • Bradykinin
  • Indomethacin